MICRON TECHNOLOGY INC, 10-Q filed on 6/25/2026
Quarterly Report
v3.26.1
Cover Page - shares
 9 Months Ended
May 28, 2026
Jun. 17, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date May 28, 2026  
Document Transition Report false  
Entity File Number 1-10658  
Entity Registrant Name Micron Technology, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 75-1618004  
Entity Address, Address Line One 8000 S. Federal Way  
Entity Address, City or Town Boise  
Entity Address, State or Province ID  
Entity Address, Postal Zip Code 83716  
City Area Code 208  
Local Phone Number 368-4000  
Title of 12(b) Security Common Stock, par value $0.10 per share  
Trading Symbol MU  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,129,393,151
Entity Central Index Key 0000723125  
Current Fiscal Year End Date --09-03  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Income Statement [Abstract]        
Revenue $ 41,456 $ 9,301 $ 78,959 $ 26,063
Cost of goods sold 6,400 5,793 18,502 16,244
Gross margin 35,056 3,508 60,457 9,819
Research and development 1,316 965 3,737 2,751
Selling, general, and administrative 407 318 1,088 891
Other operating (income) expense, net 15 56 43 61
Operating income 33,318 2,169 55,589 6,116
Interest income 215 135 509 350
Interest expense 0 (123) (106) (353)
Other non-operating income (expense), net (321) (68) (559) (90)
Income (loss) before income taxes and equity in net income (loss) of equity method investees 33,212 2,113 55,433 6,023
Income tax (provision) benefit (4,978) (235) (8,178) (695)
Equity in net income (loss) of equity method investees 9 7 13 10
Net income $ 28,243 $ 1,885 $ 47,268 $ 5,338
Earnings per share        
Basic (in dollars per share) $ 25.03 $ 1.69 $ 41.97 $ 4.79
Diluted (in dollars per share) $ 24.67 $ 1.68 $ 41.40 $ 4.75
Number of shares used in per share calculations        
Basic (in shares) 1,128 1,118 1,126 1,114
Diluted (in shares) 1,145 1,125 1,142 1,123
v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Statement of Comprehensive Income [Abstract]        
Net income $ 28,243 $ 1,885 $ 47,268 $ 5,338
Other comprehensive income (loss), net of tax        
Gains (losses) on derivative instruments 68 149 15 93
Unrealized gains (losses) on investments (11) (3) (8) (3)
Pension liability adjustments (1) 0 (1) (1)
Other comprehensive income (loss) 56 146 6 89
Total comprehensive income $ 28,299 $ 2,031 $ 47,274 $ 5,427
v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Assets    
Cash and cash equivalents $ 24,995 $ 9,642
Short-term investments 1,027 665
Receivables 31,025 9,265
Inventories 8,567 8,355
Other current assets 1,123 914
Total current assets 66,737 28,841
Long-term marketable investments [1] 4,106 1,629
Property, plant, and equipment 56,426 46,590
Operating lease right-of-use assets 683 736
Intangible assets 473 453
Deferred tax assets 700 616
Goodwill 1,150 1,150
Other noncurrent assets 3,837 2,783
Total assets 134,112 82,798
Liabilities and equity    
Accounts payable and accrued expenses 15,521 9,649
Current debt 582 560
Other current liabilities 3,385 1,245
Total current liabilities 19,488 11,454
Long-term debt 5,140 14,017
Noncurrent operating lease liabilities 654 701
Noncurrent unearned government incentives 1,020 1,018
Other noncurrent liabilities 7,086 1,443
Total liabilities 33,388 28,633
Commitments and contingencies
Shareholders’ equity    
Common stock, $0.10 par value, 3,000 shares authorized, 1,275 shares issued and 1,129 outstanding (1,266 shares issued and 1,122 outstanding as of August 28, 2025) 128 127
Additional capital 14,442 13,339
Retained earnings 94,682 48,583
Treasury stock, 146 shares held (144 shares as of August 28, 2025) (8,502) (7,852)
Accumulated other comprehensive income (loss) (26) (32)
Total equity 100,724 54,165
Total liabilities and equity $ 134,112 $ 82,798
[1] The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.
v3.26.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
shares in Millions
May 28, 2026
Aug. 28, 2025
Shareholders’ equity    
Common Stock, par value (in dollars per share) $ 0.10 $ 0.10
Common Stock, authorized shares (in shares) 3,000 3,000
Common Stock, issued (in shares) 1,275 1,266
Common Stock, outstanding (in shares) 1,129 1,122
Treasury Stock, held (in shares) 146 144
v3.26.1
STATEMENT OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Aug. 29, 2024   1,253        
Balance of total equity at Aug. 29, 2024 $ 45,131 $ 125 $ 12,115 $ 40,877 $ (7,852) $ (134)
Increase (decrease) in stockholders' equity            
Net income 5,338     5,338    
Other comprehensive income (loss), net 89         89
Stock issued under equity compensation plans (in shares)   13        
Stock issued under equity compensation plans 153 $ 1 152      
Stock-based compensation expense 722   722      
Repurchase of stock – withholdings on employee equity awards (in shares)   (3)        
Repurchase of stock – withholdings on employee equity awards $ (291) $ 0 (29) (262)    
Dividends and dividend equivalents declared (per share) $ 0.345          
Dividends and dividend equivalents declared $ (394)     (394)    
Balance (in shares) at May. 29, 2025   1,263        
Balance of total equity at May. 29, 2025 50,748 $ 126 12,960 45,559 (7,852) (45)
Balance (in shares) at Feb. 27, 2025   1,262        
Balance of total equity at Feb. 27, 2025 48,633 $ 126 12,711 43,839 (7,852) (191)
Increase (decrease) in stockholders' equity            
Net income 1,885     1,885    
Other comprehensive income (loss), net 146         146
Stock issued under equity compensation plans (in shares)   2        
Stock issued under equity compensation plans 1 $ 0 1      
Stock-based compensation expense 253   253      
Repurchase of stock – withholdings on employee equity awards (in shares)   (1)        
Repurchase of stock – withholdings on employee equity awards $ (39) $ 0 (5) (34)    
Dividends and dividend equivalents declared (per share) $ 0.115          
Dividends and dividend equivalents declared $ (131)     (131)    
Balance (in shares) at May. 29, 2025   1,263        
Balance of total equity at May. 29, 2025 $ 50,748 $ 126 12,960 45,559 (7,852) (45)
Balance (in shares) at Aug. 28, 2025 1,266 1,266        
Balance of total equity at Aug. 28, 2025 $ 54,165 $ 127 13,339 48,583 (7,852) (32)
Increase (decrease) in stockholders' equity            
Net income 47,268     47,268    
Other comprehensive income (loss), net 6         6
Stock issued under equity compensation plans (in shares)   12        
Stock issued under equity compensation plans 179 $ 1 178      
Stock-based compensation expense 954   954      
Repurchase of stock – repurchase program (650)       (650)  
Repurchase of stock – withholdings on employee equity awards (in shares)   (3)        
Repurchase of stock – withholdings on employee equity awards $ (762) $ 0 (29) (733)    
Dividends and dividend equivalents declared (per share) $ 0.38          
Dividends and dividend equivalents declared $ (436)     (436)    
Balance (in shares) at May. 28, 2026 1,275 1,275        
Balance of total equity at May. 28, 2026 $ 100,724 $ 128 14,442 94,682 (8,502) (26)
Balance (in shares) at Feb. 26, 2026   1,274        
Balance of total equity at Feb. 26, 2026 72,459 $ 127 14,092 66,824 (8,502) (82)
Increase (decrease) in stockholders' equity            
Net income 28,243     28,243    
Other comprehensive income (loss), net 56         56
Stock issued under equity compensation plans (in shares)   2        
Stock issued under equity compensation plans 0 $ 1 (1)      
Stock-based compensation expense 355   355      
Repurchase of stock – withholdings on employee equity awards (in shares)   (1)        
Repurchase of stock – withholdings on employee equity awards $ (217) $ 0 (4) (213)    
Dividends and dividend equivalents declared (per share) $ 0.15          
Dividends and dividend equivalents declared $ (172)     (172)    
Balance (in shares) at May. 28, 2026 1,275 1,275        
Balance of total equity at May. 28, 2026 $ 100,724 $ 128 $ 14,442 $ 94,682 $ (8,502) $ (26)
v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
May 28, 2026
May 29, 2025
Cash flows from operating activities    
Net income $ 47,268 $ 5,338
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense and amortization of intangible assets 6,862 6,203
Stock-based compensation 954 722
Change in operating assets and liabilities:    
Receivables (19,953) (123)
Inventories (212) 148
Accounts payable and accrued expenses 3,329 38
Other current liabilities 2,139 (681)
Other noncurrent liabilities 5,203 259
Other 112 (109)
Net cash provided by operating activities 45,702 11,795
Cash flows from investing activities    
Expenditures for property, plant, and equipment (19,602) (10,199)
Purchases of available-for-sale securities (4,072) (1,203)
Proceeds from government incentives 2,989 1,294
Proceeds from maturities and sales of available-for-sale securities 1,233 1,249
Other (236) (30)
Net cash used for investing activities (19,688) (8,889)
Cash flows from financing activities    
Repayments of debt (9,380) (3,604)
Repurchases of common stock - withholdings on employee equity awards (762) (290)
Repurchases of common stock - repurchase program (650) 0
Payments of dividends to shareholders (437) (392)
Proceeds from issuance of debt 0 4,430
Other 583 70
Net cash provided by (used for) financing activities (10,646) 214
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash 8 (3)
Net increase in cash, cash equivalents, and restricted cash 15,376 3,117
Cash, cash equivalents, and restricted cash at beginning of period 9,646 7,052
Cash, cash equivalents, and restricted cash at end of period 25,022 10,169
Supplemental disclosure    
Non-cash acquisitions of finance lease right-of-use assets $ 32 $ 1,247
v3.26.1
Significant Accounting Policies
 9 Months Ended
May 28, 2026
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
For a discussion of our significant accounting policies, see Part II, Item 8. Financial Statements and Supplementary Data, Notes to Consolidated Financial Statements, Note 1. Significant Accounting Policies of our Annual Report on Form 10-K for the year ended August 28, 2025. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended August 28, 2025.

Basis of Presentation

The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 28, 2025.

In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior-period amounts to conform to current-period presentation.

Our fiscal year is the 52- or 53-week period ending on the Thursday closest to August 31. Fiscal year 2026 contains 53 weeks and fiscal year 2025 contains 52 weeks. Our fourth quarter of fiscal year 2026 contains 14 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 28, 2025.
v3.26.1
Recently Issued Accounting Standards
 9 Months Ended
May 28, 2026
Accounting Changes and Error Corrections [Abstract]  
Recently Issued Accounting Standards Recently Issued Accounting Standards
In December 2023, the FASB issued ASU 2023-09 (ASC Topic 740), Improvements to Income Tax Disclosures. This ASU requires disaggregated income tax disclosures on the rate reconciliation and income taxes paid. This ASU will be effective for our annual reporting for 2026 on a prospective basis, with retrospective application permitted. Adoption of this new guidance will result in expanded disclosures in the Notes to Consolidated Financial Statements.

In November 2024, the FASB issued ASU 2024-03 (ASC Topic 220), Disaggregation of Income Statement Expenses. This ASU requires disclosure of certain expenses in the notes to the financial statements. This ASU will be effective for our annual reporting for 2028 on a prospective basis, with retrospective application permitted. Adoption of this new guidance will result in expanded disclosures in the Notes to Consolidated Financial Statements.

In September 2025, the FASB issued ASU 2025-06 (ASC Topic 350), Targeted Improvements to the Accounting for Internal-Use Software. This ASU makes targeted improvements to the accounting for internal-use software and will be effective for the first quarter of 2029, with early adoption permitted. This ASU provides for adoption on a prospective basis, with retrospective or modified retrospective application permitted. We are evaluating the timing and effects of our adoption of this new guidance on our financial statements.
In December 2025, the FASB issued ASU 2025-10 (ASC Topic 832), Accounting for Government Grants Received by Business Entities. This ASU establishes the accounting and presentation for government grants received by a business entity. The ASU will be effective for the first quarter of 2030, with early adoption permitted. This ASU provides for adoption either on a modified prospective, modified retrospective, or retrospective basis. We are evaluating the timing and effects of our adoption of this new guidance on our financial statements.
v3.26.1
Variable Interest Entities
 9 Months Ended
May 28, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entities Variable Interest Entities
Certain third-party special purpose entities (the “Lease SPEs”) facilitate equipment lease financing transactions between us and various financial institutions. Neither we nor the financial institutions have an equity interest in the Lease SPEs, which are variable interest entities. The arrangements are financing vehicles and we do not bear any significant risks from variable interests with the Lease SPEs. We do not have the power to direct the activities of the Lease SPEs that most significantly impact their economic performance and, as such, we do not consolidate them. We had approximately $1.34 billion and $1.58 billion of financial lease liabilities and right-of-use assets under these arrangements as of May 28, 2026 and August 28, 2025, respectively.
v3.26.1
Cash and Investments
 9 Months Ended
May 28, 2026
Investments and Cash [Abstract]  
Cash and Investments Cash and Investments
All of our short-term investments and long-term marketable investments were classified as available for sale as of the dates noted below. Cash and cash equivalents and the fair values of our available-for-sale securities, which approximated amortized costs, were as follows:
As of May 28, 2026As of August 28, 2025
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash$18,427 $— $— $18,427 $7,875 $— $— $7,875 
Level 1(2)
Money market funds70 — — 70 410 — — 410 
Level 2(3)
Certificates of deposit6,180 6 — 6,186 1,292 6 — 1,298 
Corporate bonds68 844 2,982 3,894 23 559 1,047 1,629 
Asset-backed securities— 74 1,083 1,157 — 31 521 552 
Commercial paper
247 50 — 297 33 26 — 59 
Government securities
3 53 41 97 9 43 61 113 
24,995 $1,027 $4,106 $30,128 9,642 $665 $1,629 $11,936 
Restricted cash(4)
27 4 
Cash, cash equivalents, and restricted cash$25,022 $9,646 
(1)The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.
(2)The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
(3)The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 28, 2026 or August 28, 2025.
(4)Restricted cash is included in other current assets.

Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented.

Non-marketable Equity Investments

In addition to the amounts included in the table above, we had $185 million and $194 million of non-marketable equity investments without a readily determinable fair value that were included in other noncurrent assets as of May 28, 2026 and August 28, 2025, respectively. Our non-marketable equity investments are recorded at cost
minus impairment, if any, adjusted for qualifying observable price changes. Subsequent to May 28, 2026, we purchased non-marketable equity securities in a leading AI company.
v3.26.1
Receivables
 9 Months Ended
May 28, 2026
Receivables [Abstract]  
Receivables Receivables
As ofMay 28,
2026		August 28,
2025
Trade receivables$26,894 $7,163 
Government incentives
3,408 1,572 
Income and other taxes517 436 
Other206 94 
$31,025 $9,265 
v3.26.1
Inventories
 9 Months Ended
May 28, 2026
Inventory Disclosure [Abstract]  
Inventories Inventories
As ofMay 28,
2026		August 28,
2025
Finished goods$621 $1,094 
Work in process6,960 6,401 
Raw materials and supplies986 860 
$8,567 $8,355 
v3.26.1
Property, Plant, and Equipment
 9 Months Ended
May 28, 2026
Property, Plant and Equipment [Abstract]  
Property, Plant, and Equipment Property, Plant, and Equipment
As ofMay 28,
2026		August 28,
2025
Land$420 $420 
Buildings23,741 22,173 
Equipment(1)
88,113 79,934 
Construction in progress(2)
10,935 5,518 
Software1,782 1,651 
 124,991 109,696 
Accumulated depreciation(68,565)(63,106)
 $56,426 $46,590 
(1)Includes costs related to equipment not placed into service of $4.20 billion as of May 28, 2026 and $4.05 billion as of August 28, 2025.
(2)Primarily includes building-related construction and tool installation.

On November 19, 2025, we finalized an incentive arrangement for the expansion of our Singapore manufacturing facilities, followed by a second arrangement on April 17, 2026, for the expansion of our Singapore R&D. Under both arrangements, we will receive government support for qualified capital spending and labor costs. The incentive arrangements may be subject to reduction, recapture, or termination if certain conditions are not met. Terms and conditions are subject to the confidentiality provisions of the incentive arrangements.

In March 2026, we completed the acquisition of a wafer fabrication facility in Tongluo, Miaoli County, Taiwan, from Powerchip Semiconductor Manufacturing Corporation for total cash consideration of $1.8 billion.
v3.26.1
Accounts Payable and Accrued Expenses
 9 Months Ended
May 28, 2026
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Expenses Accounts Payable and Accrued Expenses
As ofMay 28,
2026		August 28,
2025
Accounts payable$3,649 $3,132 
Property, plant, and equipment6,914 4,391 
Income and other taxes2,795 628 
Salaries, wages, and benefits1,884 1,116 
Other279 382 
$15,521 $9,649 
v3.26.1
Debt
 9 Months Ended
May 28, 2026
Debt Disclosure [Abstract]  
Debt Debt
As of May 28, 2026As of August 28, 2025
Net Carrying AmountNet Carrying Amount
Stated RateEffective RateCurrentLong-TermTotalCurrentLong-TermTotal
2031 Notes
5.300 %5.41 %$— $261 $261 $— $995 $995 
2032 Green Bonds2.703 %2.77 %— 996 996 — 996 996 
2032 Notes
5.650 %5.79 %— 70 70 — 496 496 
2033 A Notes5.875 %5.96 %— 175 175 — 746 746 
2033 B Notes5.875 %6.01 %— 213 213 — 892 892 
2035 A Notes5.800 %5.90 %— 135 135 — 992 992 
2035 B Notes6.050 %6.14 %— 219 219 — 1,241 1,241 
2041 Notes3.366 %3.41 %— 497 497 — 497 497 
2051 Notes3.477 %3.52 %— 486 486 — 496 496 
2028 NotesN/AN/A— — — — 540 540 
2029 Term Loan AN/AN/A— — — — 982 982 
2029 A NotesN/AN/A— — — — 698 698 
2029 B NotesN/AN/A— — — — 1,168 1,168 
2030 NotesN/AN/A— — — — 794 794 
Finance lease obligations
N/A4.72 %582 2,088 2,670 560 2,484 3,044 
 
$582 $5,140 $5,722 $560 $14,017 $14,577 

As of May 28, 2026, the fair value of our outstanding debt instruments approximated the carrying value of our debt. The fair value of our debt instruments was estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

Debt Activity

The table below presents the effects of debt prepayment activity in the first nine months of 2026:
Transaction Date
Decrease in Principal
Decrease in Carrying Value
Decrease in Cash
Prepayments
2028 Notes
October 24, 2025
$(542)$(541)$(562)
2029 B Notes
October 24, 2025
(1,159)(1,168)(1,276)
2029 Term Loan A
October 27, 2025
(984)(982)(984)
2051 Notes
January 23, 2026(10)(10)(7)
2029 A Notes
February 20, 2026(700)(698)(726)
2030 NotesFebruary 23, 2026(796)(794)(816)
2031 Notes
April 3, 2026
(738)(734)(773)
2032 Notes
April 3, 2026(429)(426)(456)
2033 A Notes
April 3, 2026(574)(571)(616)
2033 B Notes
April 3, 2026(685)(679)(734)
2035 A Notes
April 3, 2026(864)(857)(921)
2035 B Notes
April 3, 2026(1,030)(1,022)(1,114)
$(8,511)$(8,482)$(8,985)

In connection with these prepayments, we recognized losses in other non-operating income (expense) of $323 million and $500 million for the third quarter and first nine months of 2026, respectively.

Revolving Credit Facility

On May 6, 2026, we reduced our borrowing capacity under the Revolving Credit Facility from $3.50 billion to $2.00 billion. As of May 28, 2026, no amounts were outstanding under the Revolving Credit Facility. Borrowing under the Revolving Credit Facility would generally bear interest at a rate equal to adjusted term SOFR plus 0.875% to 1.50%, depending on our corporate credit ratings. Any amounts outstanding under the Revolving Credit Facility would mature on March 12, 2030 and amounts borrowed may be prepaid without penalty. Any obligations under the Revolving Credit Facility would be unsecured.

The Revolving Credit Facility requires us to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, subject to a temporary four fiscal quarter increase in such maximum ratio to 3.75 to 1.00 following certain material acquisitions.
v3.26.1
Contingencies
 9 Months Ended
May 28, 2026
Loss Contingency [Abstract]  
Contingencies Contingencies
We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition.

Patent Matters

As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. A description of certain claims is below.

On April 28, 2021, Netlist, Inc. (“Netlist”) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. (“MSP”), and Micron Technology Texas, LLC (“MTEC”) in the U.S. District Court for the Western District of Texas (“W.D. Tex.”). The first complaint alleges that one U.S. patent is infringed by certain of our non-volatile dual in-line memory modules. The second complaint alleges that three U.S. patents are infringed by certain of our load-reduced dual in-line memory modules (“LRDIMMs”). Each complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor (Deutschland) GmbH (“MSG”) in Düsseldorf Regional Court alleging that two German
patents are infringed by certain of our LRDIMMs. The complaint seeks damages, costs, and injunctive relief. In rulings issued on March 7, 2024 and November 7, 2024, the Federal Patent Court in Germany declared both patents invalid. Netlist appealed those rulings. On May 21, 2026, the appeals court affirmed the ruling of invalidity of the first patent. The appeal regarding the second patent has not yet been decided.

On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. On August 1, 2022, Netlist filed a second patent infringement complaint against the same defendants in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. On August 15, 2022, Netlist amended the second complaint to assert that two additional U.S. patents are infringed by certain of our LRDIMMs. The complaints in E.D. Tex. seek injunctive relief, damages, and attorneys’ fees. On May 23, 2024, following a four-day trial regarding the second complaint filed by Netlist in the E.D. Tex., a jury rendered a verdict that Micron’s memory modules infringe two asserted patents—U.S. Patent No. 7,619,912 (“the ‘912 patent”) and U.S. Patent No. 11,093,417 (“the ‘417 patent”)—and found that Micron should pay $425 million for infringement of the ‘912 patent and $20 million for infringement of the ‘417 patent. On July 9, 2025, Micron filed a notice that it will appeal the judgment. On April 17, 2024, the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) issued a final written decision (“FWD”) finding unpatentable the sole asserted claim of the ‘912 patent. On September 10, 2024, Netlist filed a notice that it will appeal the ruling that the ‘912 patent is unpatentable to the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”). On July 30, 2024, the USPTO issued a FWD finding unpatentable all asserted claims of the ‘417 patent. On December 10, 2024, Netlist filed a notice that it will appeal the ruling that the ‘417 patent is unpatentable to the Federal Circuit. In the case of each of the ‘912 and ‘417 patents, if the United States Court of Appeals for the Federal Circuit affirms the FWD, then the affirmed FWD will preclude any pending actions asserting infringement of such patent (including enforcement of the infringement verdict).

On May 19, 2025, Netlist filed a complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that one U.S. patent is infringed by our HBM products. On July 8, 2025, Netlist amended the complaint to allege that one additional U.S. patent is infringed by certain of our DIMMs. On March 6, 2026, the E.D. Tex. transferred the case to the United States District Court for the District of Delaware (“D. Del.”) pursuant to a motion by Micron to dismiss or transfer for improper venue. On July 28, 2025, Netlist filed an additional complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that one U.S. patent is infringed by certain of our DIMMs. On April 1, 2026, the E.D. Tex. transferred the additional case to D. Del. These complaints seek damages, attorneys’ fees, and other equitable relief.

On January 23, 2023, BeSang Inc. filed a patent infringement complaint against Micron in E.D. Tex. The complaint alleges that one U.S. patent is infringed by certain of our 3D NAND and SSD products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On September 17, 2025, the District Court issued a judgment that the accused products do not infringe the asserted patent. On October 17, 2025, BeSang filed a notice of appeal of the District Court’s judgment.

On November 9, 2023, Yangtze Memory Technologies Company, Ltd. (“YMTC”) filed a patent infringement complaint against Micron and one of its subsidiaries in the U.S. District Court for the Northern District of California (“N.D. Cal.”). The complaint alleges that eight U.S. patents are infringed by certain of our 3D NAND products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On January 22, 2024, Micron Semiconductor (Shanghai) Co., Ltd. (“MSS”) was served with three patent infringement complaints filed by YMTC in Beijing Intellectual Property Court and on February 27, 2024, Micron was served with the same complaints. The complaints assert that Micron and MSS infringed three Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On July 12, 2024, YMTC filed a second complaint against Micron and its subsidiary in N.D. Cal. The second complaint alleges that eleven U.S. patents are infringed by certain of our 3D NAND and DDR5 DRAM products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On September 11, 2024, MSS was served with five patent infringement complaints filed by YMTC in Shanghai Intellectual Property Court. The complaints assert that Micron and MSS infringed five Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys’ fees, and costs.

On October 6, 2025, YMTC filed several patent infringement complaints against Micron and certain of its subsidiaries alleging that the Company’s manufacture, importation, sale, offering for sale, and/or assisting others to
sell certain NAND and DRAM products infringe certain patents owned by YMTC. Specifically, YMTC filed the following complaints: A patent infringement complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that seven patents are infringed by certain of our 3D NAND products and one patent is infringed by certain of our LPDRAM products; a patent infringement complaint in the London Chancery Division of the English High Court against Micron and Micron Europe Limited (“MEL”) alleging that three patents are infringed by certain of our NAND and DRAM products; three complaints against Micron and various combinations of subsidiaries, including MEL, MSP, MSG, and Micron Semiconductor France SAS in the Unified Patent Court in Dusseldorf, Germany, alleging that three patents are infringed by certain of our 3D NAND and LPDRAM products; and five complaints against Micron, MEL, and MSG in Munich Regional Court in Munich, Germany, alleging that five patents are infringed by certain of our 3D NAND products. Each of the complaints filed against us by YMTC on October 6, 2025, seeks an injunction, attorneys’ fees, damages, and costs.

On June 30, 2025, Advanced Memory Technologies, LLC (“AMT”) filed a patent infringement complaint against Micron in W.D. Tex. alleging that four U.S. patents are infringed by certain of our DRAM and NAND products. On November 4, 2025, AMT amended the complaint to allege that a fifth patent is infringed by certain of our DRAM products. The complaint seeks an injunction, damages, attorneys’ fees, and costs.

On March 6, 2026, Nextech Semiconductor, LLC (“Nextech”) filed a patent infringement complaint against Micron and MSP in W.D. Tex. alleging that six U.S. patents are infringed by certain of our DRAM, NAND, and SSD products. The complaint seeks an injunction, damages, attorneys’ fees and costs.

The above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue.

Securities Class Action Matters

On January 9, 2025, a putative class action complaint was filed against Micron and certain officers in the U.S. District Court for the Southern District of Florida for alleged violations of the Securities Exchange Act of 1934. On April 3, 2025, the case was transferred to the United States District Court for the District of Idaho (“D. Idaho”), and on May 23, 2025, an amended complaint was filed in D. Idaho. The amended complaint alleged that defendants made materially false or misleading statements regarding industry supply and demand dynamics and the demand for Micron's products. On February 3, 2026, the court dismissed the amended complaint but granted plaintiffs leave to file a further amended complaint. On April 3, 2026, the plaintiffs voluntarily dismissed the case.

Shareholder Derivative Matters

On February 20 and 21, 2025, two shareholder derivative complaints were filed against certain directors and officers of Micron, allegedly on behalf of and for the benefit of Micron, in D. Idaho. The complaints alleged violations of the Securities Exchange Act of 1934, breach of fiduciary duty, unjust enrichment, insider trading, abuse of control, and waste of corporate assets and were based on substantially the same statements asserted in the securities class action. On April 28, 2025, the complaints were consolidated and on May 14, 2025, the consolidated action was stayed. Following the dismissal of the securities class action, the consolidated action was dismissed.

On September 8, 2025, a substantially similar shareholder derivative complaint was filed in D. Del. On April 24, 2026, the action was dismissed.
Other Matters

On June 7, 2025, YMTC filed a complaint against Micron and DCI Group AZ, LLC in the U.S. District Court for the District of Columbia. The complaint alleges that the defendants engaged in false advertising, product disparagement, and unfair competition regarding YMTC’s 3D NAND flash products in violation of the Lanham Act. The complaint seeks injunctive relief, damages, disgorgement of profits, attorneys’ fees, and costs.

On January 16, 2026, Neighbors for a Better Micron and Jobs to Move America filed a petition in the Supreme Court of New York against Micron, one of our subsidiaries, Onondaga County Industrial Development Agency (“OCIDA”), and certain other state and local government entities. The petition challenges certain aspects of OCIDA’s environmental review of the Company’s planned construction of up to four fabs in Clay, New York, and seeks a judgment to annul, vacate, and void all permits, approvals, and findings issued by the named government entities related to the project. The petition further seeks costs and attorneys’ fees.

In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.

Contingency Assessment

We are unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.
v3.26.1
Equity
 9 Months Ended
May 28, 2026
Equity [Abstract]  
Equity Equity
Common Stock Repurchases

Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions, restrictions applicable under our CHIPS Act direct funding agreements, and our ongoing determination of the best use of available cash. No shares were repurchased in the third quarter of 2026. We repurchased 2.5 million shares of our common stock for $650 million in first nine months of 2026. Through May 28, 2026, we had repurchased an aggregate of $7.84 billion under the authorization. Amounts repurchased are included in treasury stock.

Dividends

We declared and paid dividends of $0.115 per share in the first and second quarters of 2026 and $0.15 per share in the third quarter of 2026. On June 24, 2026, our Board of Directors declared a quarterly dividend of $0.15 per share, payable in cash on July 21, 2026, to shareholders of record as of the close of business on July 6, 2026.
v3.26.1
Derivative Instruments
 9 Months Ended
May 28, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments
Notional or Contractual Amount
Fair Value(1) of
Assets(2)
Liabilities(3)
As of May 28, 2026
Derivative instruments with hedge accounting designation
Cash flow currency hedges
$4,096 $7 $(106)
Cash flow commodity hedges406 105 (7)
Fair value currency hedges
5,568 19 — 
Derivative instruments without hedge accounting designation
Non-designated currency hedges
12,431 15 (48)
$146 $(161)
As of August 28, 2025
Derivative instruments with hedge accounting designation
Cash flow currency hedges
$3,271 $41 $(64)
Cash flow commodity hedges393 19 (20)
Fair value currency hedges3,049 1 (10)
Derivative instruments without hedge accounting designation
Non-designated currency hedges
3,477 3 (18)
$64 $(112)
(1)Forward and swap contracts are measured at fair value based on market-based observable inputs, including market spot and forward rates, interest rates, and credit-risk spreads (Level 2).
(2)Included in receivables and other noncurrent assets.
(3)Included in accounts payable and accrued expenses and other noncurrent liabilities.

Derivative Instruments with Hedge Accounting Designation

Cash Flow Hedges: We utilize forward contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs.

Fair Value Hedges: We utilize currency forward contracts that generally mature within one year designated as fair value hedges to minimize our exposure to changes in currency exchange rates for non-U.S.-dollar-denominated cash and investments in debt securities. The fair value of our hedged cash and investments in debt securities was $5.54 billion and $3.05 billion as of May 28, 2026 and August 28, 2025, respectively. The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings.
Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: We generally utilize a rolling hedge strategy with currency forward contracts that mature within one year to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Realized and unrealized gains and losses on derivative instruments without hedge accounting designation, as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates, are included in other non-operating income (expense), net.

Gains and losses from our derivative instruments were not material for the periods presented.
v3.26.1
Equity Compensation Plans
 9 Months Ended
May 28, 2026
Share-Based Payment Arrangement [Abstract]  
Equity Compensation Plans Equity Compensation Plans
As of May 28, 2026, 48 million shares of our common stock were available for future awards under our equity compensation plans, including 7 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)

Nine Months EndedMay 28,
2026		May 29,
2025
Restricted stock award shares granted711
Weighted-average grant-date fair value per share$227.18 $100.25 

Employee Stock Purchase Plan (“ESPP”)

Employees purchased 2 million shares in each six-month ESPP offering period that ended in the second quarter of 2026 and 2025 at a share price of $92.77 and $78.63, respectively.

Stock-based Compensation Expense

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $132 million and $96 million was capitalized and remained in inventory as of May 28, 2026 and August 28, 2025, respectively.

Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Stock-based compensation expense by caption
Cost of goods sold$143 $115 $371 $294 
Research and development129 89 355 254 
Selling, general, and administrative69 59 192 165 
$341 $263 $918 $713 
Stock-based compensation expense by type of award
Restricted stock awards$309 $239 $829 $643 
ESPP32 24 89 70 
$341 $263 $918 $713 
As of May 28, 2026, $2.13 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the third quarter of 2030, resulting in a weighted-average period of 1.2 years.
v3.26.1
Revenue and Customer Contract Liabilities
 9 Months Ended
May 28, 2026
Revenue from Contract with Customer [Abstract]  
Revenue and Customer Contract Liabilities Revenue and Customer Contract Liabilities
Revenue by Technology

Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
DRAM$31,328 $7,071 $60,908 $19,594 
NAND9,943 2,155 17,683 6,251 
Other (primarily NOR)
185 75 368 218 
$41,456 $9,301 $78,959 $26,063 

See Item 1. Financial Statements, Notes to Consolidated Financial Statements, Note 17. Segment and Other Information for disclosure of disaggregated revenue by market segment.

We recently executed certain strategic customer agreements, including agreements executed subsequent to May 28, 2026. These agreements are structured as take-or-pay agreements, with binding commitments for specific volumes over the multi-year contract terms and include contractually enforceable volumes. Pricing for most agreements is either fixed, or is subject to minimum and maximum pricing. A minority of the agreements do not have any fixed pricing or price bands, as pricing for those agreements is subject to market conditions.

Our remaining performance obligations disclosure is based on minimum committed volumes and minimum pricing and is not expected to be indicative of future revenue under these contracts. Agreements without fixed pricing or price bands are not included in the remaining performance obligations disclosure. As a practical expedient, we have excluded contracts that have an original term of one year or less from our remaining performance obligations disclosure.

As of May 28, 2026, the transaction price allocated to our remaining performance obligations was approximately $5 billion, of which $422 million has been recognized as contract liabilities. Contract liabilities primarily consisted of customer deposits associated with strategic customer agreements for which revenue has not yet been recognized and are primarily included in other noncurrent liabilities. As of August 28, 2025, our remaining performance obligations were not material. Approximately one-third of the remaining performance obligations as of May 28, 2026 are expected to be recognized as revenue over the next twelve months.

As of May 28, 2026 and August 28, 2025, other current liabilities included $3.32 billion and $1.19 billion, respectively, for estimates of consideration payable to customers, including pricing adjustments and returns.
v3.26.1
Income Taxes
 9 Months Ended
May 28, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Our income tax (provision) benefit consisted of the following:
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Income before taxes
$33,212 $2,113 $55,433 $6,023 
Income tax (provision) benefit(4,978)(235)(8,178)(695)
Effective tax rate15.0 %11.1 %14.8 %11.5 %

The change in our effective tax rate for the third quarter and first nine months of 2026, as compared to the corresponding periods of 2025, was primarily due to the 15% minimum tax Pillar Two Model Rules (“Pillar Two”). Singapore enacted legislation to implement Pillar Two, effective for us in 2026, which largely offsets the benefit from our Singapore tax incentive arrangements.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted, introducing broad changes to the U.S. tax code, including modifications to corporate and international tax provisions, which primarily are effective for us beginning in 2026 and 2027. The aggregate impact of the OBBBA remains uncertain. We will continue to monitor future developments, including regulatory guidance and interpretations, which could have a material impact on our income tax provision.

Other noncurrent liabilities included $5.79 billion and $648 million related to income taxes payable as of May 28, 2026 and August 28, 2025, respectively.
v3.26.1
Earnings Per Share
 9 Months Ended
May 28, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Net income – Basic and Diluted
$28,243 $1,885 $47,268 $5,338 
Weighted-average common shares outstanding – Basic1,128 1,118 1,126 1,114 
Dilutive effect of equity compensation plans
17 7 16 9 
Weighted-average common shares outstanding – Diluted1,145 1,125 1,142 1,123 
Earnings per share
Basic$25.03 $1.69 $41.97 $4.79 
Diluted24.67 1.68 41.40 4.75 

Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were not material for the third quarter or first nine months of 2026 and were 7 million shares and 10 million shares for the third quarter and first nine months of 2025, respectively.
v3.26.1
Segment and Other Information
 9 Months Ended
May 28, 2026
Segment Reporting [Abstract]  
Segment and Other Information Segment and Other Information
Segment information reported herein is consistent with the way our Chief Executive Officer, who is our Chief Operating Decision Maker (“CODM”), assesses the performance of our segments based on segment revenue, cost of goods sold, operating expenses, and operating income. The segment information reported herein is regularly provided to and reviewed and evaluated by our CODM to budget, forecast, and decide how to allocate resources for capital investments, human capital, and other strategic investments across our segments.

We have the following four business units, which are based on market segments and our reportable segments:

•Cloud Memory Business Unit (“CMBU”): Focused on memory solutions for large hyperscale cloud customers, and HBM for all data center customers.
•Core Data Center Business Unit (“CDBU”): Focused on memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers.
•Mobile and Client Business Unit (“MCBU”): Focused on memory and storage solutions for the mobile and client segments.
•Automotive and Embedded Business Unit (“AEBU”): Focused on memory and storage solutions for the automotive, industrial, and consumer segments.

Our other operations do not meet the thresholds of a reportable segment and are reported under All Other. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. Certain income and expenses are not allocated to segments because our CODM does not consider these amounts in the assessment of the performance of our segments. Substantially all of the unallocated amounts are related to stock-based compensation. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.
Quarter Ended May 28, 2026
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$13,769 $11,524 $11,521 $4,634 $8 $— $41,456 
Cost of goods sold2,278 1,537 1,463 975 4 143 6,400 
Gross margin11,491 9,987 10,058 3,659 4 (143)35,056 
Research and development592 391 107 96 — 130 1,316 
Selling, general, and administrative108 79 81 70 — 69 407 
Other operating (income) expense, net(2)(2)(3)— 1 21 15 
Operating income
$10,793 $9,519 $9,873 $3,493 $3 $(363)$33,318 

Quarter Ended May 29, 2025
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$3,386 $1,530 $3,255 $1,127 $3 $— $9,301 
Cost of goods sold1,415 956 2,467 837 3 115 5,793 
Gross margin1,971 574 788 290 — (115)3,508 
Research and development337 223 201 114 1 89 965 
Selling, general, and administrative61 45 105 49 (1)59 318 
Other operating (income) expense, net— (1)— 1 (2)58 56 
Operating income
$1,573 $307 $482 $126 $2 $(321)$2,169 

Nine Months Ended May 28, 2026
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$26,802 $19,590 $23,487 $9,062 $18 $— $78,959 
Cost of goods sold6,097 4,155 5,090 2,776 13 371 18,502 
Gross margin20,705 15,435 18,397 6,286 5 (371)60,457 
Research and development1,628 1,040 409 302 — 358 3,737 
Selling, general, and administrative274 177 263 182 — 192 1,088 
Other operating (income) expense, net(1)— (1)— — 45 43 
Operating income
$18,804 $14,218 $17,726 $5,802 $5 $(966)$55,589 

Nine Months Ended May 29, 2025
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$8,981 $5,652 $8,099 $3,319 $12 $— $26,063 
Cost of goods sold4,025 3,072 6,260 2,579 10 298 16,244 
Gross margin4,956 2,580 1,839 740 2 (298)9,819 
Research and development851 644 671 330 1 254 2,751 
Selling, general, and administrative146 147 290 144 (1)165 891 
Other operating (income) expense, net— — 1 1 1 58 61 
Operating income
$3,959 $1,789 $877 $265 $1 $(775)$6,116 
Depreciation and amortization expense included in operating income was as follows:
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
CMBU$780 $548 $2,291 $1,600 
CDBU550 361 1,534 1,193 
MCBU678 877 2,005 2,361 
AEBU353 306 1,024 1,040 
All Other2 2 5 5 
Unallocated1 — 3 4 
$2,364 $2,094 $6,862 $6,203 

Revenue from one customer was 10% and 16% (primarily included in the CMBU segment) of total revenue for the first nine months of 2026 and 2025, respectively.

As of May 28, 2026 and August 28, 2025, CMBU, CDBU, MCBU, and AEBU had goodwill of $654 million, $109 million, $284 million, and $103 million, respectively.
v3.26.1
Insider Trading Arrangements
 3 Months Ended
May 28, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Significant Accounting Policies (Policies)
 9 Months Ended
May 28, 2026
Accounting Policies [Abstract]  
Basis of Presentation The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 28, 2025.
Reclassifications Certain reclassifications have been made to prior-period amounts to conform to current-period presentation.
Fiscal Period
Our fiscal year is the 52- or 53-week period ending on the Thursday closest to August 31. Fiscal year 2026 contains 53 weeks and fiscal year 2025 contains 52 weeks. Our fourth quarter of fiscal year 2026 contains 14 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 28, 2025.
v3.26.1
Segment and Other Information (Policies)
 9 Months Ended
May 28, 2026
Segment Reporting [Abstract]  
Segment Reporting Policy
We have the following four business units, which are based on market segments and our reportable segments:

•Cloud Memory Business Unit (“CMBU”): Focused on memory solutions for large hyperscale cloud customers, and HBM for all data center customers.
•Core Data Center Business Unit (“CDBU”): Focused on memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers.
•Mobile and Client Business Unit (“MCBU”): Focused on memory and storage solutions for the mobile and client segments.
•Automotive and Embedded Business Unit (“AEBU”): Focused on memory and storage solutions for the automotive, industrial, and consumer segments.

Our other operations do not meet the thresholds of a reportable segment and are reported under All Other. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. Certain income and expenses are not allocated to segments because our CODM does not consider these amounts in the assessment of the performance of our segments. Substantially all of the unallocated amounts are related to stock-based compensation. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.
v3.26.1
Cash and Investments (Tables)
 9 Months Ended
May 28, 2026
Investments and Cash [Abstract]  
Cash, cash equivalents, and available-for-sale securities
All of our short-term investments and long-term marketable investments were classified as available for sale as of the dates noted below. Cash and cash equivalents and the fair values of our available-for-sale securities, which approximated amortized costs, were as follows:
As of May 28, 2026As of August 28, 2025
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash$18,427 $— $— $18,427 $7,875 $— $— $7,875 
Level 1(2)
Money market funds70 — — 70 410 — — 410 
Level 2(3)
Certificates of deposit6,180 6 — 6,186 1,292 6 — 1,298 
Corporate bonds68 844 2,982 3,894 23 559 1,047 1,629 
Asset-backed securities— 74 1,083 1,157 — 31 521 552 
Commercial paper
247 50 — 297 33 26 — 59 
Government securities
3 53 41 97 9 43 61 113 
24,995 $1,027 $4,106 $30,128 9,642 $665 $1,629 $11,936 
Restricted cash(4)
27 4 
Cash, cash equivalents, and restricted cash$25,022 $9,646 
(1)The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.
(2)The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
(3)The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 28, 2026 or August 28, 2025.
(4)Restricted cash is included in other current assets.
Cash and cash equivalents and the fair values of available-for-sale securities
All of our short-term investments and long-term marketable investments were classified as available for sale as of the dates noted below. Cash and cash equivalents and the fair values of our available-for-sale securities, which approximated amortized costs, were as follows:
As of May 28, 2026As of August 28, 2025
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash and Cash Equivalents
Short-term Investments
Long-term Marketable Investments(1)
Total Fair Value
Cash$18,427 $— $— $18,427 $7,875 $— $— $7,875 
Level 1(2)
Money market funds70 — — 70 410 — — 410 
Level 2(3)
Certificates of deposit6,180 6 — 6,186 1,292 6 — 1,298 
Corporate bonds68 844 2,982 3,894 23 559 1,047 1,629 
Asset-backed securities— 74 1,083 1,157 — 31 521 552 
Commercial paper
247 50 — 297 33 26 — 59 
Government securities
3 53 41 97 9 43 61 113 
24,995 $1,027 $4,106 $30,128 9,642 $665 $1,629 $11,936 
Restricted cash(4)
27 4 
Cash, cash equivalents, and restricted cash$25,022 $9,646 
(1)The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.
(2)The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
(3)The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 28, 2026 or August 28, 2025.
(4)Restricted cash is included in other current assets.
v3.26.1
Receivables (Tables)
 9 Months Ended
May 28, 2026
Receivables [Abstract]  
Schedule of receivables
As ofMay 28,
2026		August 28,
2025
Trade receivables$26,894 $7,163 
Government incentives
3,408 1,572 
Income and other taxes517 436 
Other206 94 
$31,025 $9,265 
v3.26.1
Inventories (Tables)
 9 Months Ended
May 28, 2026
Inventory Disclosure [Abstract]  
Schedule of inventories
As ofMay 28,
2026		August 28,
2025
Finished goods$621 $1,094 
Work in process6,960 6,401 
Raw materials and supplies986 860 
$8,567 $8,355 
v3.26.1
Property, Plant, and Equipment (Tables)
 9 Months Ended
May 28, 2026
Property, Plant and Equipment [Abstract]  
Schedule of property, plant, and equipment
As ofMay 28,
2026		August 28,
2025
Land$420 $420 
Buildings23,741 22,173 
Equipment(1)
88,113 79,934 
Construction in progress(2)
10,935 5,518 
Software1,782 1,651 
 124,991 109,696 
Accumulated depreciation(68,565)(63,106)
 $56,426 $46,590 
(1)Includes costs related to equipment not placed into service of $4.20 billion as of May 28, 2026 and $4.05 billion as of August 28, 2025.
(2)Primarily includes building-related construction and tool installation.
v3.26.1
Accounts Payable and Accrued Expenses (Tables)
 9 Months Ended
May 28, 2026
Payables and Accruals [Abstract]  
Schedule of accounts payable and accrued expenses
As ofMay 28,
2026		August 28,
2025
Accounts payable$3,649 $3,132 
Property, plant, and equipment6,914 4,391 
Income and other taxes2,795 628 
Salaries, wages, and benefits1,884 1,116 
Other279 382 
$15,521 $9,649 
v3.26.1
Debt (Tables)
 9 Months Ended
May 28, 2026
Debt Disclosure [Abstract]  
Schedule of debt
As of May 28, 2026As of August 28, 2025
Net Carrying AmountNet Carrying Amount
Stated RateEffective RateCurrentLong-TermTotalCurrentLong-TermTotal
2031 Notes
5.300 %5.41 %$— $261 $261 $— $995 $995 
2032 Green Bonds2.703 %2.77 %— 996 996 — 996 996 
2032 Notes
5.650 %5.79 %— 70 70 — 496 496 
2033 A Notes5.875 %5.96 %— 175 175 — 746 746 
2033 B Notes5.875 %6.01 %— 213 213 — 892 892 
2035 A Notes5.800 %5.90 %— 135 135 — 992 992 
2035 B Notes6.050 %6.14 %— 219 219 — 1,241 1,241 
2041 Notes3.366 %3.41 %— 497 497 — 497 497 
2051 Notes3.477 %3.52 %— 486 486 — 496 496 
2028 NotesN/AN/A— — — — 540 540 
2029 Term Loan AN/AN/A— — — — 982 982 
2029 A NotesN/AN/A— — — — 698 698 
2029 B NotesN/AN/A— — — — 1,168 1,168 
2030 NotesN/AN/A— — — — 794 794 
Finance lease obligations
N/A4.72 %582 2,088 2,670 560 2,484 3,044 
 
$582 $5,140 $5,722 $560 $14,017 $14,577 
Schedule of debt activity
The table below presents the effects of debt prepayment activity in the first nine months of 2026:
Transaction Date
Decrease in Principal
Decrease in Carrying Value
Decrease in Cash
Prepayments
2028 Notes
October 24, 2025
$(542)$(541)$(562)
2029 B Notes
October 24, 2025
(1,159)(1,168)(1,276)
2029 Term Loan A
October 27, 2025
(984)(982)(984)
2051 Notes
January 23, 2026(10)(10)(7)
2029 A Notes
February 20, 2026(700)(698)(726)
2030 NotesFebruary 23, 2026(796)(794)(816)
2031 Notes
April 3, 2026
(738)(734)(773)
2032 Notes
April 3, 2026(429)(426)(456)
2033 A Notes
April 3, 2026(574)(571)(616)
2033 B Notes
April 3, 2026(685)(679)(734)
2035 A Notes
April 3, 2026(864)(857)(921)
2035 B Notes
April 3, 2026(1,030)(1,022)(1,114)
$(8,511)$(8,482)$(8,985)
v3.26.1
Derivative Instruments (Tables)
 9 Months Ended
May 28, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivative instruments
Notional or Contractual Amount
Fair Value(1) of
Assets(2)
Liabilities(3)
As of May 28, 2026
Derivative instruments with hedge accounting designation
Cash flow currency hedges
$4,096 $7 $(106)
Cash flow commodity hedges406 105 (7)
Fair value currency hedges
5,568 19 — 
Derivative instruments without hedge accounting designation
Non-designated currency hedges
12,431 15 (48)
$146 $(161)
As of August 28, 2025
Derivative instruments with hedge accounting designation
Cash flow currency hedges
$3,271 $41 $(64)
Cash flow commodity hedges393 19 (20)
Fair value currency hedges3,049 1 (10)
Derivative instruments without hedge accounting designation
Non-designated currency hedges
3,477 3 (18)
$64 $(112)
(1)Forward and swap contracts are measured at fair value based on market-based observable inputs, including market spot and forward rates, interest rates, and credit-risk spreads (Level 2).
(2)Included in receivables and other noncurrent assets.
(3)Included in accounts payable and accrued expenses and other noncurrent liabilities.
v3.26.1
Equity Compensation Plans (Tables)
 9 Months Ended
May 28, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of restricted stock awards activity
Nine Months EndedMay 28,
2026		May 29,
2025
Restricted stock award shares granted711
Weighted-average grant-date fair value per share$227.18 $100.25 
Stock-based compensation expense
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Stock-based compensation expense by caption
Cost of goods sold$143 $115 $371 $294 
Research and development129 89 355 254 
Selling, general, and administrative69 59 192 165 
$341 $263 $918 $713 
Stock-based compensation expense by type of award
Restricted stock awards$309 $239 $829 $643 
ESPP32 24 89 70 
$341 $263 $918 $713 
v3.26.1
Revenue and Customer Contract Liabilities (Tables)
 9 Months Ended
May 28, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of revenue by technology
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
DRAM$31,328 $7,071 $60,908 $19,594 
NAND9,943 2,155 17,683 6,251 
Other (primarily NOR)
185 75 368 218 
$41,456 $9,301 $78,959 $26,063 
v3.26.1
Income Taxes (Tables)
 9 Months Ended
May 28, 2026
Income Tax Disclosure [Abstract]  
Schedule of components of income tax (provision) benefit
Our income tax (provision) benefit consisted of the following:
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Income before taxes
$33,212 $2,113 $55,433 $6,023 
Income tax (provision) benefit(4,978)(235)(8,178)(695)
Effective tax rate15.0 %11.1 %14.8 %11.5 %
v3.26.1
Earnings Per Share (Tables)
 9 Months Ended
May 28, 2026
Earnings Per Share [Abstract]  
Basic and diluted earnings per share
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
Net income – Basic and Diluted
$28,243 $1,885 $47,268 $5,338 
Weighted-average common shares outstanding – Basic1,128 1,118 1,126 1,114 
Dilutive effect of equity compensation plans
17 7 16 9 
Weighted-average common shares outstanding – Diluted1,145 1,125 1,142 1,123 
Earnings per share
Basic$25.03 $1.69 $41.97 $4.79 
Diluted24.67 1.68 41.40 4.75 
v3.26.1
Segment and Other Information (Tables)
 9 Months Ended
May 28, 2026
Segment Reporting [Abstract]  
Schedule of results by segment
Quarter Ended May 28, 2026
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$13,769 $11,524 $11,521 $4,634 $8 $— $41,456 
Cost of goods sold2,278 1,537 1,463 975 4 143 6,400 
Gross margin11,491 9,987 10,058 3,659 4 (143)35,056 
Research and development592 391 107 96 — 130 1,316 
Selling, general, and administrative108 79 81 70 — 69 407 
Other operating (income) expense, net(2)(2)(3)— 1 21 15 
Operating income
$10,793 $9,519 $9,873 $3,493 $3 $(363)$33,318 

Quarter Ended May 29, 2025
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$3,386 $1,530 $3,255 $1,127 $3 $— $9,301 
Cost of goods sold1,415 956 2,467 837 3 115 5,793 
Gross margin1,971 574 788 290 — (115)3,508 
Research and development337 223 201 114 1 89 965 
Selling, general, and administrative61 45 105 49 (1)59 318 
Other operating (income) expense, net— (1)— 1 (2)58 56 
Operating income
$1,573 $307 $482 $126 $2 $(321)$2,169 

Nine Months Ended May 28, 2026
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$26,802 $19,590 $23,487 $9,062 $18 $— $78,959 
Cost of goods sold6,097 4,155 5,090 2,776 13 371 18,502 
Gross margin20,705 15,435 18,397 6,286 5 (371)60,457 
Research and development1,628 1,040 409 302 — 358 3,737 
Selling, general, and administrative274 177 263 182 — 192 1,088 
Other operating (income) expense, net(1)— (1)— — 45 43 
Operating income
$18,804 $14,218 $17,726 $5,802 $5 $(966)$55,589 

Nine Months Ended May 29, 2025
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$8,981 $5,652 $8,099 $3,319 $12 $— $26,063 
Cost of goods sold4,025 3,072 6,260 2,579 10 298 16,244 
Gross margin4,956 2,580 1,839 740 2 (298)9,819 
Research and development851 644 671 330 1 254 2,751 
Selling, general, and administrative146 147 290 144 (1)165 891 
Other operating (income) expense, net— — 1 1 1 58 61 
Operating income
$3,959 $1,789 $877 $265 $1 $(775)$6,116 
Schedule of depreciation and amortization expense by segment
Depreciation and amortization expense included in operating income was as follows:
Quarter EndedNine Months Ended
May 28,
2026		May 29,
2025		May 28,
2026		May 29,
2025
CMBU$780 $548 $2,291 $1,600 
CDBU550 361 1,534 1,193 
MCBU678 877 2,005 2,361 
AEBU353 306 1,024 1,040 
All Other2 2 5 5 
Unallocated1 — 3 4 
$2,364 $2,094 $6,862 $6,203 
v3.26.1
Variable Interest Entities (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Variable interest entity    
Finance leases, liability $ 2,670 $ 3,044
Variable interest entity, not primary beneficiary    
Variable interest entity    
Finance leases, right-of-use asset 1,340 1,580
Finance leases, liability $ 1,340 $ 1,580
v3.26.1
Cash and Investments (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
May 29, 2025
Aug. 29, 2024
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents $ 24,995 $ 9,642    
Short-term investments 1,027 665    
Long-term marketable investments [1] 4,106 1,629    
Total fair value 30,128 11,936    
Restricted cash [2] 27 4    
Cash, cash equivalents, and restricted cash 25,022 9,646 $ 10,169 $ 7,052
Non-marketable Equity Investments        
Non-marketable equity investments without readily determinable fair value (Level 3) $ 185 194    
Minimum        
Cash, cash equivalents, and available-for-sale securities        
Long-term marketable investments, range of maturities 1 year      
Maximum        
Cash, cash equivalents, and available-for-sale securities        
Long-term marketable investments, range of maturities 5 years      
Cash        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents $ 18,427 7,875    
Short-term investments 0 0    
Long-term marketable investments 0 0    
Total fair value 18,427 7,875    
Money market funds | Level 1        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [3] 70 410    
Short-term investments [3] 0 0    
Long-term marketable investments [1],[3] 0 0    
Total fair value [3] 70 410    
Certificates of deposit | Level 2        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [4] 6,180 1,292    
Short-term investments [4] 6 6    
Long-term marketable investments [1],[4] 0 0    
Total fair value [4] 6,186 1,298    
Corporate bonds | Level 2        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [4] 68 23    
Short-term investments [4] 844 559    
Long-term marketable investments [1],[4] 2,982 1,047    
Total fair value [4] 3,894 1,629    
Asset-backed securities | Level 2        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [4] 0 0    
Short-term investments [4] 74 31    
Long-term marketable investments [1],[4] 1,083 521    
Total fair value [4] 1,157 552    
Commercial paper | Level 2        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [4] 247 33    
Short-term investments [4] 50 26    
Long-term marketable investments [1],[4] 0 0    
Total fair value [4] 297 59    
Government securities | Level 2        
Cash, cash equivalents, and available-for-sale securities        
Cash and cash equivalents [4] 3 9    
Short-term investments [4] 53 43    
Long-term marketable investments [1],[4] 41 61    
Total fair value [4] $ 97 $ 113    
[1] The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.
[2] Restricted cash is included in other current assets.
[3] The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[4] The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 28, 2026 or August 28, 2025.
v3.26.1
Receivables (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Receivables [Abstract]    
Trade receivables $ 26,894 $ 7,163
Government incentives 3,408 1,572
Income and other taxes 517 436
Other 206 94
Receivables $ 31,025 $ 9,265
v3.26.1
Inventories (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Inventory, net of reserves    
Finished goods $ 621 $ 1,094
Work in process 6,960 6,401
Raw materials and supplies 986 860
Inventories $ 8,567 $ 8,355
v3.26.1
Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
 1 Months Ended
Mar. 31, 2026
May 28, 2026
Aug. 28, 2025
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross   $ 124,991 $ 109,696
Accumulated depreciation   (68,565) (63,106)
Property, plant, and equipment, net   56,426 46,590
Land      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross   420 420
Buildings      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross   23,741 22,173
Equipment (including not placed into service)      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross [1]   88,113 79,934
Equipment not placed into service      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross   4,200 4,050
Construction in progress      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross [2]   10,935 5,518
Software      
Property, plant, and equipment including finance lease right-of-use asset      
Property, plant, and equipment, gross   $ 1,782 $ 1,651
Tongluo Taiwan Manufacturing Facility      
Tongluo, Miaolo County, Taiwan manufacturing facility acquisition      
PPE addition of Tongluo, Taiwan facility $ 1,800    
Cash paid to acquire Tongluo, Taiwan facility $ 1,800    
[1] Includes costs related to equipment not placed into service of $4.20 billion as of May 28, 2026 and $4.05 billion as of August 28, 2025.
[2] Primarily includes building-related construction and tool installation.
v3.26.1
Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Accounts payable and accrued liabilities, current    
Accounts payable $ 3,649 $ 3,132
Property, plant, and equipment 6,914 4,391
Income and other taxes 2,795 628
Salaries, wages, and benefits 1,884 1,116
Other 279 382
Total accounts payable and accrued expenses $ 15,521 $ 9,649
v3.26.1
Debt - Long-term Debt (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Long-term debt by current and noncurrent    
Finance lease effective rate (in ten thousandths) 4.72%  
Current finance lease obligations $ 582 $ 560
Long-term finance lease obligations 2,088 2,484
Total finance lease obligations 2,670 3,044
Long-term debt and lease obligation    
Current debt (including finance lease obligation) 582 560
Long-term debt (including finance lease obligation) 5,140 14,017
Total net carrying amount of debt (including finance lease obligation) $ 5,722 $ 14,577
Current finance lease liability, statement of financial position Current debt (including finance lease obligation) Current debt (including finance lease obligation)
Noncurrent finance lease liability, statement of financial position Long-term debt (including finance lease obligation) Long-term debt (including finance lease obligation)
Corporate bonds | 2031 Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 5.30%  
Effective rate (in ten thousandths) 5.41%  
Current portion of long-term debt $ 0 $ 0
Noncurrent long-term debt 261 995
Total long-term debt $ 261 995
Corporate bonds | 2032 Green Bonds    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 2.703%  
Effective rate (in ten thousandths) 2.77%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 996 996
Total long-term debt $ 996 996
Corporate bonds | 2032 Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 5.65%  
Effective rate (in ten thousandths) 5.79%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 70 496
Total long-term debt $ 70 496
Corporate bonds | 2033 A Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 5.875%  
Effective rate (in ten thousandths) 5.96%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 175 746
Total long-term debt $ 175 746
Corporate bonds | 2033 B Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 5.875%  
Effective rate (in ten thousandths) 6.01%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 213 892
Total long-term debt $ 213 892
Corporate bonds | 2035 A Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 5.80%  
Effective rate (in ten thousandths) 5.90%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 135 992
Total long-term debt $ 135 992
Corporate bonds | 2035 B Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 6.05%  
Effective rate (in ten thousandths) 6.14%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 219 1,241
Total long-term debt $ 219 1,241
Corporate bonds | 2041 Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 3.366%  
Effective rate (in ten thousandths) 3.41%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 497 497
Total long-term debt $ 497 497
Corporate bonds | 2051 Notes    
Long-term debt by current and noncurrent    
Stated rate (exact percentage) 3.477%  
Effective rate (in ten thousandths) 3.52%  
Current portion of long-term debt $ 0 0
Noncurrent long-term debt 486 496
Total long-term debt 486 496
Corporate bonds | 2028 Notes    
Long-term debt by current and noncurrent    
Current portion of long-term debt 0 0
Noncurrent long-term debt 0 540
Total long-term debt 0 540
Corporate bonds | 2029 A Notes    
Long-term debt by current and noncurrent    
Current portion of long-term debt 0 0
Noncurrent long-term debt 0 698
Total long-term debt 0 698
Corporate bonds | 2029 B Notes    
Long-term debt by current and noncurrent    
Current portion of long-term debt 0 0
Noncurrent long-term debt 0 1,168
Total long-term debt 0 1,168
Corporate bonds | 2030 Notes    
Long-term debt by current and noncurrent    
Current portion of long-term debt 0 0
Noncurrent long-term debt 0 794
Total long-term debt 0 794
Term loan | 2029 Term Loan A    
Long-term debt by current and noncurrent    
Current portion of long-term debt 0 0
Noncurrent long-term debt 0 982
Total long-term debt $ 0 $ 982
v3.26.1
Debt - Activity (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Apr. 03, 2026
Feb. 23, 2026
Feb. 20, 2026
Jan. 23, 2026
Oct. 27, 2025
Oct. 24, 2025
May 28, 2026
May 28, 2026
Debt instrument                
Decrease in principal               $ (8,511)
Decrease in carrying value               (8,482)
Decrease in cash               (8,985)
Loss on debt prepayments             $ 323 $ 500
2028 Notes | Corporate bonds                
Debt instrument                
Decrease in principal           $ (542)    
Decrease in carrying value           (541)    
Decrease in cash           (562)    
2029 B Notes | Corporate bonds                
Debt instrument                
Decrease in principal           (1,159)    
Decrease in carrying value           (1,168)    
Decrease in cash           $ (1,276)    
2029 Term Loan A | Term loan                
Debt instrument                
Decrease in principal         $ (984)      
Decrease in carrying value         (982)      
Decrease in cash         $ (984)      
2051 Notes | Corporate bonds                
Debt instrument                
Decrease in principal       $ (10)        
Decrease in carrying value       (10)        
Decrease in cash       $ (7)        
2029 A Notes | Corporate bonds                
Debt instrument                
Decrease in principal     $ (700)          
Decrease in carrying value     (698)          
Decrease in cash     $ (726)          
2030 Notes | Corporate bonds                
Debt instrument                
Decrease in principal   $ (796)            
Decrease in carrying value   (794)            
Decrease in cash   $ (816)            
2031 Notes | Corporate bonds                
Debt instrument                
Decrease in principal $ (738)              
Decrease in carrying value (734)              
Decrease in cash (773)              
2032 Notes | Corporate bonds                
Debt instrument                
Decrease in principal (429)              
Decrease in carrying value (426)              
Decrease in cash (456)              
2033 A Notes | Corporate bonds                
Debt instrument                
Decrease in principal (574)              
Decrease in carrying value (571)              
Decrease in cash (616)              
2033 B Notes | Corporate bonds                
Debt instrument                
Decrease in principal (685)              
Decrease in carrying value (679)              
Decrease in cash (734)              
2035 A Notes | Corporate bonds                
Debt instrument                
Decrease in principal (864)              
Decrease in carrying value (857)              
Decrease in cash (921)              
2035 B Notes | Corporate bonds                
Debt instrument                
Decrease in principal (1,030)              
Decrease in carrying value (1,022)              
Decrease in cash $ (1,114)              
v3.26.1
Debt - Revolving Credit Facility (Details) - Revolving credit facility - 2030 Revolving Credit Facility - USD ($)
 9 Months Ended
May 28, 2026
May 05, 2026
Revolving credit facility    
Maximum borrowing capacity $ 2,000,000,000.00 $ 3,500,000,000
Total long-term debt 0  
Available borrowing capacity $ 2,000,000,000.00  
Debt instrument, variable interest rate, type Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]  
Debt instrument, covenant description The Revolving Credit Facility requires us to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, subject to a temporary four fiscal quarter increase in such maximum ratio to 3.75 to 1.00 following certain material acquisitions.  
Minimum    
Revolving credit facility    
Debt instrument, basis spread on variable rate 0.875%  
Maximum    
Revolving credit facility    
Debt instrument, basis spread on variable rate 1.50%  
Debt instrument, covenant, ratio of net debt to adjusted EBITDA 325.00%  
Debt instrument, covenant, ratio of net debt to adjusted EBITDA, temporary increase after material acquisition 375.00%  
v3.26.1
Contingencies (Details)
$ in Millions
 9 Months Ended
May 28, 2026
USD ($)
patent
Netlist Inc. vs Micron - Complaint 1 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Netlist Inc. vs Micron - Complaint 2 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 3
Netlist Inc. vs Micron - Complaint 3 | Patent matters  
Loss contingencies  
Number of patents found invalid 1
Netlist Inc. vs Micron - Complaint 3 | Patent matters | Litigation under appeal  
Loss contingencies  
Number of patents found invalid 2
Netlist Inc. vs Micron - Complaint 4 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 6
Netlist Inc. vs Micron - Complaint 5 | Patent matters  
Loss contingencies  
Number of patents allegedly infringed 1
Netlist Inc. vs Micron - Complaint 5 amendment | Patent matters | Litigation under appeal  
Loss contingencies  
Number of patents allegedly infringed 2
Number of patents found infringed (jury) 2
Netlist Inc. vs Micron - Complaint 5 amendment | Patent 7,619,912 | Litigation under appeal  
Loss contingencies  
Damages awarded to Netlist (jury) | $ $ 425
Number of patents found unpatentable by US Patent and Trademark Office 1
Netlist Inc. vs Micron - Complaint 5 amendment | Patent 11,093,417 | Litigation under appeal  
Loss contingencies  
Damages awarded to Netlist (jury) | $ $ 20
Number of patents found unpatentable by US Patent and Trademark Office 1
Netlist Inc. vs Micron - Complaint 6 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Netlist Inc. vs Micron - Complaint 6 amendment | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Netlist Inc. vs Micron - Complaint 7 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Besang, Inc. vs Micron | Patent matters | Litigation under appeal  
Loss contingencies  
Number of patents allegedly infringed 1
Number of patents found not infringed 1
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaint 1 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 8
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaints 2, 3, 4 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 3
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaint 5 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 11
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaint 6_7_8_9_10 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 5
Yangtze Memory Technologies Company, Ltd. Complaint 11a | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 7
Yangtze Memory Technologies Company, Ltd. Complaint 11b | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Yangtze Memory Technologies Company, Ltd. Complaint 12 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 3
Yangtze Memory Technologies Company, Ltd. Complaint 13_14_15 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 3
Yangtze Memory Technologies Company, Ltd. Complaint 16_17_18_19_20 | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 5
Advanced Memory Technologies LLC vs Micron | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 4
Advanced Memory Technologies LLC Complaint amendment | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 1
Nextech Semiconductor LLC vs Micron | Patent matters | Pending litigation  
Loss contingencies  
Number of patents allegedly infringed 6
v3.26.1
Equity - Common Stock Repurchases and Dividends (Details) - USD ($)
 3 Months Ended 9 Months Ended 97 Months Ended
Jun. 24, 2026
May 28, 2026
Feb. 26, 2026
Nov. 27, 2025
May 29, 2025
May 28, 2026
May 29, 2025
May 28, 2026
Common stock repurchases                
Payments for repurchase of common stock           $ 650,000,000 $ 0  
Dividends                
Payments of dividends to shareholders (per share)   $ 0.15 $ 0.115 $ 0.115        
Cash dividends declared (per share)   $ 0.15     $ 0.115 $ 0.38 $ 0.345  
R2026Q3 Dividends | Subsequent event                
Dividends                
Cash dividends declared (per share) $ 0.15              
Dividends payable, date to be paid Jul. 21, 2026              
Dividends payable, date of record Jul. 06, 2026              
Repurchases authorized by the BOD                
Common stock repurchases                
Common stock repurchase, authorized amount   $ 10,000,000,000       $ 10,000,000,000   $ 10,000,000,000
Treasury shares repurchased (in shares)   0       2,500,000    
Payments for repurchase of common stock           $ 650,000,000   $ 7,840,000,000
v3.26.1
Derivative Instruments - Notional Amounts and Fair Values (Details) - USD ($)
$ in Millions
May 28, 2026
Aug. 28, 2025
Fair value of derivative assets and liabilities    
Fair value of assets (Level 2) [1],[2] $ 146 $ 64
Fair value of liabilities (Level 2) [2],[3] (161) (112)
Designated hedging instruments | Cash flow hedges | Currency hedges    
Notional disclosures    
Notional or contractual amount 4,096 3,271
Fair value of derivative assets and liabilities    
Fair value of assets (Level 2) [1],[2] 7 41
Fair value of liabilities (Level 2) [2],[3] (106) (64)
Designated hedging instruments | Cash flow hedges | Commodity hedges    
Notional disclosures    
Notional or contractual amount 406 393
Fair value of derivative assets and liabilities    
Fair value of assets (Level 2) [1],[2] 105 19
Fair value of liabilities (Level 2) [2],[3] (7) (20)
Designated hedging instruments | Fair value hedges | Currency hedges    
Notional disclosures    
Notional or contractual amount 5,568 3,049
Fair value of derivative assets and liabilities    
Fair value of assets (Level 2) [1],[2] 19 1
Fair value of liabilities (Level 2) [2],[3] 0 (10)
Not designated hedging instruments | Currency hedges    
Notional disclosures    
Notional or contractual amount 12,431 3,477
Fair value of derivative assets and liabilities    
Fair value of assets (Level 2) [1],[2] 15 3
Fair value of liabilities (Level 2) [2],[3] $ (48) $ (18)
[1] Included in receivables and other noncurrent assets.
[2] Forward and swap contracts are measured at fair value based on market-based observable inputs, including market spot and forward rates, interest rates, and credit-risk spreads (Level 2).
[3] Included in accounts payable and accrued expenses and other noncurrent liabilities.
v3.26.1
Derivative Instruments - Other Details (Details) - USD ($)
$ in Millions
 9 Months Ended
May 28, 2026
Aug. 28, 2025
Designated hedging instruments | Cash flow hedges    
Derivative instruments with and without hedge accounting designation    
General maturity of derivative instruments (in years) 2 years  
Designated hedging instruments | Fair value hedges | Currency hedges    
Derivative instruments with and without hedge accounting designation    
General maturity of derivative instruments (in years) 1 year  
Fair value hedges    
Fair value of hedged cash and investments $ 5,540 $ 3,050
Not designated hedging instruments | Currency hedges    
Derivative instruments with and without hedge accounting designation    
General maturity of derivative instruments (in years) 1 year  
v3.26.1
Equity Compensation Plans - Share Based Information and Restricted Stock Awards (Details) - $ / shares
shares in Millions
 6 Months Ended 9 Months Ended
Feb. 26, 2026
Feb. 27, 2025
May 28, 2026
May 29, 2025
Share-based compensation arrangement by share-based payment award        
Number of shares available for future awards (in shares)     48  
ESPP        
Share-based compensation arrangement by share-based payment award        
Number of shares available for future awards (in shares)     7  
Employee Stock Purchase Plan ("ESPP")        
ESPP offering period 6 months 6 months    
ESPP, number of shares purchased by employees 2 2    
ESPP, purchase price per share paid by employees $ 92.77 $ 78.63    
Restricted stock awards        
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")        
Restricted stock award shares granted     7 11
Weighted-average grant-date fair value per share     $ 227.18 $ 100.25
v3.26.1
Equity Compensation Plans - Stock-based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Aug. 28, 2025
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense $ 341 $ 263 $ 918 $ 713  
Equity plans, additional disclosures          
Total unrecognized compensation costs related to non-vested awards expected to be recognized 2,130   $ 2,130    
Weighted-average period that unrecognized compensation costs is expected to be recognized (in years)     1 year 2 months 12 days    
Restricted stock awards          
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense 309 239 $ 829 643  
ESPP          
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense 32 24 89 70  
Equity plans          
Equity plans, additional disclosures          
Expense capitalized and remained in inventory 132   132   $ 96
Cost of goods sold          
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense 143 115 371 294  
Research and development          
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense 129 89 355 254  
Selling, general, and administrative          
Share-based payment arrangement, expensed and capitalized, amount          
Stock-based compensation expense $ 69 $ 59 $ 192 $ 165  
v3.26.1
Revenue by Technology (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Disaggregation of revenue        
Revenue $ 41,456 $ 9,301 $ 78,959 $ 26,063
DRAM        
Disaggregation of revenue        
Revenue 31,328 7,071 60,908 19,594
NAND        
Disaggregation of revenue        
Revenue 9,943 2,155 17,683 6,251
Other (primarily NOR)        
Disaggregation of revenue        
Revenue $ 185 $ 75 $ 368 $ 218
v3.26.1
Customer Contract Liabilities (Details) - USD ($)
$ in Millions
 9 Months Ended
May 28, 2026
Aug. 28, 2025
Remaining performance obligation    
Remaining performance obligation, practical expedient exemption for contracts one year or less true  
Remaining performance obligation $ 5,000  
Contract with customer, contract liability    
Customer contract liability 422  
Contract with customer, right of return    
Estimated consideration payable to customers , including for pricing adjustments and returns $ 3,320 $ 1,190
Start date for expected timing of remaining performance obligation: 2026-05-29    
Remaining performance obligation    
Remaining performance obligation, percentage to be recognized 33.30%  
Remaining performance obligation, expected period of timing of satisfaction 1 year  
v3.26.1
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Aug. 28, 2025
Income Tax Disclosure [Abstract]          
Income before taxes $ 33,212 $ 2,113 $ 55,433 $ 6,023  
Income tax (provision) benefit $ (4,978) $ (235) $ (8,178) $ (695)  
Effective tax rate 15.00% 11.10% 14.80% 11.50%  
Noncurrent income taxes payable $ 5,790   $ 5,790   $ 648
v3.26.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Earnings per share reconciliation        
Net income (loss) - Basic $ 28,243 $ 1,885 $ 47,268 $ 5,338
Net income (loss) - Diluted $ 28,243 $ 1,885 $ 47,268 $ 5,338
Weighted-average number of shares outstanding reconciliation        
Weighted-average common shares outstanding – Basic 1,128 1,118 1,126 1,114
Dilutive effect of equity compensation plans 17 7 16 9
Weighted-average common shares outstanding – Diluted 1,145 1,125 1,142 1,123
Basic (in dollars per share) $ 25.03 $ 1.69 $ 41.97 $ 4.79
Diluted (in dollars per share) $ 24.67 $ 1.68 $ 41.40 $ 4.75
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)   7   10
v3.26.1
Segment and Other Information - Results by Segment (Details)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
USD ($)
May 29, 2025
USD ($)
May 28, 2026
USD ($)
segment
May 29, 2025
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     4  
Segment reporting information        
Revenue $ 41,456 $ 9,301 $ 78,959 $ 26,063
Cost of goods sold 6,400 5,793 18,502 16,244
Gross margin 35,056 3,508 60,457 9,819
Research and development 1,316 965 3,737 2,751
Selling, general, and administrative 407 318 1,088 891
Other operating (income) expense, net 15 56 43 61
Operating income 33,318 2,169 55,589 6,116
Operating segments | CMBU        
Segment reporting information        
Revenue 13,769 3,386 26,802 8,981
Cost of goods sold 2,278 1,415 6,097 4,025
Gross margin 11,491 1,971 20,705 4,956
Research and development 592 337 1,628 851
Selling, general, and administrative 108 61 274 146
Other operating (income) expense, net (2) 0 (1) 0
Operating income 10,793 1,573 18,804 3,959
Operating segments | CDBU        
Segment reporting information        
Revenue 11,524 1,530 19,590 5,652
Cost of goods sold 1,537 956 4,155 3,072
Gross margin 9,987 574 15,435 2,580
Research and development 391 223 1,040 644
Selling, general, and administrative 79 45 177 147
Other operating (income) expense, net (2) (1) 0 0
Operating income 9,519 307 14,218 1,789
Operating segments | MCBU        
Segment reporting information        
Revenue 11,521 3,255 23,487 8,099
Cost of goods sold 1,463 2,467 5,090 6,260
Gross margin 10,058 788 18,397 1,839
Research and development 107 201 409 671
Selling, general, and administrative 81 105 263 290
Other operating (income) expense, net (3) 0 (1) 1
Operating income 9,873 482 17,726 877
Operating segments | AEBU        
Segment reporting information        
Revenue 4,634 1,127 9,062 3,319
Cost of goods sold 975 837 2,776 2,579
Gross margin 3,659 290 6,286 740
Research and development 96 114 302 330
Selling, general, and administrative 70 49 182 144
Other operating (income) expense, net 0 1 0 1
Operating income 3,493 126 5,802 265
Operating segments | All other        
Segment reporting information        
Revenue 8 3 18 12
Cost of goods sold 4 3 13 10
Gross margin 4 0 5 2
Research and development 0 1 0 1
Selling, general, and administrative 0 (1) 0 (1)
Other operating (income) expense, net 1 (2) 0 1
Operating income 3 2 5 1
Unallocated        
Segment reporting information        
Revenue 0 0 0 0
Cost of goods sold 143 115 371 298
Gross margin (143) (115) (371) (298)
Research and development 130 89 358 254
Selling, general, and administrative 69 59 192 165
Other operating (income) expense, net 21 58 45 58
Operating income $ (363) $ (321) $ (966) $ (775)
v3.26.1
Segment and Other Information - Depreciation and Amortization and Goodwill (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
May 28, 2026
May 29, 2025
May 28, 2026
May 29, 2025
Aug. 28, 2025
Segment reporting information          
Depreciation expense and amortization of intangible assets $ 2,364 $ 2,094 $ 6,862 $ 6,203  
Goodwill 1,150   1,150   $ 1,150
CMBU          
Segment reporting information          
Goodwill 654   654   654
CDBU          
Segment reporting information          
Goodwill 109   109   109
MCBU          
Segment reporting information          
Goodwill 284   284   284
AEBU          
Segment reporting information          
Goodwill 103   103   $ 103
Operating segments | CMBU          
Segment reporting information          
Depreciation expense and amortization of intangible assets 780 548 2,291 1,600  
Operating segments | CDBU          
Segment reporting information          
Depreciation expense and amortization of intangible assets 550 361 1,534 1,193  
Operating segments | MCBU          
Segment reporting information          
Depreciation expense and amortization of intangible assets 678 877 2,005 2,361  
Operating segments | AEBU          
Segment reporting information          
Depreciation expense and amortization of intangible assets 353 306 1,024 1,040  
Operating segments | All other          
Segment reporting information          
Depreciation expense and amortization of intangible assets 2 2 5 5  
Unallocated          
Segment reporting information          
Depreciation expense and amortization of intangible assets $ 1 $ 0 $ 3 $ 4  
v3.26.1
Segment and Other Information - Customer Concentration (Details)
 9 Months Ended
May 28, 2026
May 29, 2025
Undisclosed Customer 1 | Revenue from contract with customer | Customer concentration risk    
Segment reporting information    
Concentration risk, percentage 10.00% 16.00%